Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Honsea Sunshine Biotech is a specialized biotechnology company focused on the research, development, and industrial-scale production of natural plant extracts and active ingredients. The company utilizes advanced supercritical CO2 extraction and molecular distillation technologies to produce high-purity ingredients for the pharmaceutical, cosmetic, and nutraceutical industries. Their core product portfolio includes standardized extracts such as ginger, magnolia bark, and various essential oils known for their bioactive properties. Honsea Sunshine Biotech operates modern manufacturing facilities that comply with international quality standards, including GMP and ISO certifications. As a key subsidiary of the Honsea Group, the company serves a global market, providing natural alternatives for chemical additives in health and personal care products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Honsea Sunshine Biotech.